Diagnostic utility of coeliac disease: A descriptive study in a tertiary care hospital, Oman

Safana Salim Al Saidi, Salim Omar Al Harthi, Waad Allah Sharef Mula-Abed

Research output: Contribution to journalArticle

Abstract

Objectives: The prevalence of coeliac disease in Oman is unknown. We aim to estimate the prevalence of coeliac disease in at-risk subjects, describe the clinical characteristics and laboratory findings associated with coeliac disease and the validity of serological testing for coeliac disease at the Royal Hospital, Oman over a period of three years. Methods: This is a retrospective case finding study. The medical and laboratory records were reviewed for patients for whom serum antiendomysium IgA antibodies were requested at the Royal Hospital during a 3-year period (1st Jan 2006-31st Dec 2008). The data were extracted in order to assess the following: a) Prevalence rate of coeliac disease among at-risk subjects; b) Clinical characteristics in patients with coeliac disease and clinical manifestations for which the requesting clinicians considered coeliac disease as a possible diagnosis, including their specialties; c) Laboratory tests results in patients with coeliac disease; and d) Validity of antiendomysium antibodies testing in comparison with histopathology of jejunal biopsies for diagnosing coeliac disease. Results: The study included 431 patients (250 females, 181 males) who were suspected of having (or screened for) coeliac disease. The median of age was 15 years (range: 9 months-74 years) with mean ± SD 18.95 ± 14.1 years. Of these, 15 (3.5%) patients (10 females, 5 males) with a median age of 19 years and mean 21.4 ± 13.0 years (range: 2.5-38 years), had positive antiendomysium antibodies results with median (range) of 160 (40-320) IU/L and mean± SD 204.5 ± 160 IU/L. Of these 15 patients, 13 had positive jejunal histopathological changes indicative of coeliac disease; the remaining 2 patients had no biopsy examination. Of the 44 patients with negative antiendomysium antibodies

Original languageEnglish
Pages (from-to)232-236
Number of pages5
JournalOman Medical Journal
Volume28
Issue number4
DOIs
Publication statusPublished - 2013

Fingerprint

Oman
Celiac Disease
Tertiary Healthcare
Tertiary Care Centers
Antibodies
Biopsy
Immunoglobulin A
Medical Records

Keywords

  • Antiendomysium antibodies
  • Coeliac disease
  • Oman
  • Prevalence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Diagnostic utility of coeliac disease : A descriptive study in a tertiary care hospital, Oman. / Al Saidi, Safana Salim; Al Harthi, Salim Omar; Mula-Abed, Waad Allah Sharef.

In: Oman Medical Journal, Vol. 28, No. 4, 2013, p. 232-236.

Research output: Contribution to journalArticle

Al Saidi, Safana Salim ; Al Harthi, Salim Omar ; Mula-Abed, Waad Allah Sharef. / Diagnostic utility of coeliac disease : A descriptive study in a tertiary care hospital, Oman. In: Oman Medical Journal. 2013 ; Vol. 28, No. 4. pp. 232-236.
@article{f3ce06b5f0d14907ba69800ab7d5ba9e,
title = "Diagnostic utility of coeliac disease: A descriptive study in a tertiary care hospital, Oman",
abstract = "Objectives: The prevalence of coeliac disease in Oman is unknown. We aim to estimate the prevalence of coeliac disease in at-risk subjects, describe the clinical characteristics and laboratory findings associated with coeliac disease and the validity of serological testing for coeliac disease at the Royal Hospital, Oman over a period of three years. Methods: This is a retrospective case finding study. The medical and laboratory records were reviewed for patients for whom serum antiendomysium IgA antibodies were requested at the Royal Hospital during a 3-year period (1st Jan 2006-31st Dec 2008). The data were extracted in order to assess the following: a) Prevalence rate of coeliac disease among at-risk subjects; b) Clinical characteristics in patients with coeliac disease and clinical manifestations for which the requesting clinicians considered coeliac disease as a possible diagnosis, including their specialties; c) Laboratory tests results in patients with coeliac disease; and d) Validity of antiendomysium antibodies testing in comparison with histopathology of jejunal biopsies for diagnosing coeliac disease. Results: The study included 431 patients (250 females, 181 males) who were suspected of having (or screened for) coeliac disease. The median of age was 15 years (range: 9 months-74 years) with mean ± SD 18.95 ± 14.1 years. Of these, 15 (3.5{\%}) patients (10 females, 5 males) with a median age of 19 years and mean 21.4 ± 13.0 years (range: 2.5-38 years), had positive antiendomysium antibodies results with median (range) of 160 (40-320) IU/L and mean± SD 204.5 ± 160 IU/L. Of these 15 patients, 13 had positive jejunal histopathological changes indicative of coeliac disease; the remaining 2 patients had no biopsy examination. Of the 44 patients with negative antiendomysium antibodies",
keywords = "Antiendomysium antibodies, Coeliac disease, Oman, Prevalence",
author = "{Al Saidi}, {Safana Salim} and {Al Harthi}, {Salim Omar} and Mula-Abed, {Waad Allah Sharef}",
year = "2013",
doi = "10.5001/omj.2013.68",
language = "English",
volume = "28",
pages = "232--236",
journal = "Oman Medical Journal",
issn = "1999-768X",
publisher = "Oman Medical Specialty Board",
number = "4",

}

TY - JOUR

T1 - Diagnostic utility of coeliac disease

T2 - A descriptive study in a tertiary care hospital, Oman

AU - Al Saidi, Safana Salim

AU - Al Harthi, Salim Omar

AU - Mula-Abed, Waad Allah Sharef

PY - 2013

Y1 - 2013

N2 - Objectives: The prevalence of coeliac disease in Oman is unknown. We aim to estimate the prevalence of coeliac disease in at-risk subjects, describe the clinical characteristics and laboratory findings associated with coeliac disease and the validity of serological testing for coeliac disease at the Royal Hospital, Oman over a period of three years. Methods: This is a retrospective case finding study. The medical and laboratory records were reviewed for patients for whom serum antiendomysium IgA antibodies were requested at the Royal Hospital during a 3-year period (1st Jan 2006-31st Dec 2008). The data were extracted in order to assess the following: a) Prevalence rate of coeliac disease among at-risk subjects; b) Clinical characteristics in patients with coeliac disease and clinical manifestations for which the requesting clinicians considered coeliac disease as a possible diagnosis, including their specialties; c) Laboratory tests results in patients with coeliac disease; and d) Validity of antiendomysium antibodies testing in comparison with histopathology of jejunal biopsies for diagnosing coeliac disease. Results: The study included 431 patients (250 females, 181 males) who were suspected of having (or screened for) coeliac disease. The median of age was 15 years (range: 9 months-74 years) with mean ± SD 18.95 ± 14.1 years. Of these, 15 (3.5%) patients (10 females, 5 males) with a median age of 19 years and mean 21.4 ± 13.0 years (range: 2.5-38 years), had positive antiendomysium antibodies results with median (range) of 160 (40-320) IU/L and mean± SD 204.5 ± 160 IU/L. Of these 15 patients, 13 had positive jejunal histopathological changes indicative of coeliac disease; the remaining 2 patients had no biopsy examination. Of the 44 patients with negative antiendomysium antibodies

AB - Objectives: The prevalence of coeliac disease in Oman is unknown. We aim to estimate the prevalence of coeliac disease in at-risk subjects, describe the clinical characteristics and laboratory findings associated with coeliac disease and the validity of serological testing for coeliac disease at the Royal Hospital, Oman over a period of three years. Methods: This is a retrospective case finding study. The medical and laboratory records were reviewed for patients for whom serum antiendomysium IgA antibodies were requested at the Royal Hospital during a 3-year period (1st Jan 2006-31st Dec 2008). The data were extracted in order to assess the following: a) Prevalence rate of coeliac disease among at-risk subjects; b) Clinical characteristics in patients with coeliac disease and clinical manifestations for which the requesting clinicians considered coeliac disease as a possible diagnosis, including their specialties; c) Laboratory tests results in patients with coeliac disease; and d) Validity of antiendomysium antibodies testing in comparison with histopathology of jejunal biopsies for diagnosing coeliac disease. Results: The study included 431 patients (250 females, 181 males) who were suspected of having (or screened for) coeliac disease. The median of age was 15 years (range: 9 months-74 years) with mean ± SD 18.95 ± 14.1 years. Of these, 15 (3.5%) patients (10 females, 5 males) with a median age of 19 years and mean 21.4 ± 13.0 years (range: 2.5-38 years), had positive antiendomysium antibodies results with median (range) of 160 (40-320) IU/L and mean± SD 204.5 ± 160 IU/L. Of these 15 patients, 13 had positive jejunal histopathological changes indicative of coeliac disease; the remaining 2 patients had no biopsy examination. Of the 44 patients with negative antiendomysium antibodies

KW - Antiendomysium antibodies

KW - Coeliac disease

KW - Oman

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84880935903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880935903&partnerID=8YFLogxK

U2 - 10.5001/omj.2013.68

DO - 10.5001/omj.2013.68

M3 - Article

C2 - 23904914

AN - SCOPUS:84880935903

VL - 28

SP - 232

EP - 236

JO - Oman Medical Journal

JF - Oman Medical Journal

SN - 1999-768X

IS - 4

ER -